Therefore, it is proposed that chimeric antigen receptor T-cell approaches that directly target B7-H4 might be effective by simultaneously destroying B7-H4+ tumor cells and eliminating negative-immune modulating cells from the tumor microenvironment. This evidence concerns the gene VTCN1 and neoplasm.